More patients leaving Rxs at the pharmacy counter


More consumers abandoned new prescriptions at the pharmacy at a rate of 6.3 percent in 2009, which is up by 24 percent since 2008. According to Pharma Insight 2009 by Wolters Kluwer Pharma Solutions, the abandonment rate for new prescriptions of brand-name drugs alone was 8.6 percent in 2009, up by 23 percent from 2008, and up by an astonishing 68 percent since 2006. A prescription is considered abandoned when it is submitted to a pharmacy, but never picked up.

Dea Belazi, practice leader of managed markets at the company, says a number of factors affect abandonment — copayment is one of them.

“Patients who are new to the therapy are more likely to experience copayment shock,” says Belazi.

What this means for payers, of course, is more costs down the line. “What will that patient’s health status be?” But what happens to all those abandoned prescriptions? Belazi says the pharmacy contacts the health plan and arranges for a reverse transaction, basically a bookkeeping exercise at the end of the day.

More patients abandoning new Rxs

Source: Wolters Kluwer. Pharma Insight 2009. March 2009

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

UP NEXT

Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky